Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prolonged-release Pirfenidone in Chronic Kidney Disease
NCT02408744Phase 2Completed
- Sponsor
- Universidad de Guadalajara
- Start
- Sep 2009
- Primary completion
- Sep 2010
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of pirfenidone in chronic kidney disease (CKD), sponsored by Universidad de Guadalajara. Started Sep 2009; status: completed.
02
Drugs
pirfenidone
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT02408744.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02408744.